IMAGING OF ALPHA-SYNUCLEIN

摘要

Radiolabeled alpha-synuclein binding agents are provided that are useful in imaging alpha-synucleing deposits in the brain of subjects with a synucleinopathy or susceptible to a synucleinopathy. The agents are particularly useful in imaging via PET and SPECT nuclear medicine imaging. The imaging techniques may be used to diagnose a patient, follow the progression of disease, or follow treatment of the disease.